(Q44214923)

30 November 2017

title

Serological markers for coeliac disease: is it time to change? (English)

1 reference

30 November 2017

1 reference

Bardella MT

1

1 reference

30 November 2017

Trovato C

2

1 reference

30 November 2017

Cesana BM

3

1 reference

30 November 2017

Pagliari C

4

1 reference

30 November 2017

Gebbia C

5

1 reference

30 November 2017

Peracchi M

6

1 reference

30 November 2017

publication date

1 June 2001

1 reference

Digestive and Liver Disease

30 November 2017

published in

1 reference

30 November 2017

volume

33

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

426-431

1 reference

Fortnightly review: coeliac disease

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Is human umbilical cord the most suitable substrate for the detection of endomysium antibodies in the screening and follow-up of coeliac disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Screening test for coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Identification of tissue transglutaminase as the autoantigen of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Autoantibodies to tissue transglutaminase as predictors of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

A Coefficient of Agreement for Nominal Scales

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Coeliac disease in the year 2000: exploring the iceberg

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Association between serum levels of total IgA and IgA class endomysial and antigliadin antibodies: implications for coeliac disease screening

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Follow-up of patients positive in reticulin and gliadin antibody tests with normal small-bowel biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Tissue transglutaminase antibodies in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Tissue transglutaminase and combined screening for coeliac disease and type 1 diabetes-associated autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Evaluation of gliadin antibodies for detection of coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

Dietary intake, smoking, and transient anti-gliadin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980015-3

7 January 2021

10.1016/S1590-8658(01)80015-3

Identifiers

DOI

1 reference

30 November 2017

1 reference